944900-64-5 Usage
Uses
Used in Pharmaceutical Industry:
2,3-DIMETHOXY-4-VINYLPYRIDINE is used as a building block for the preparation of various pharmaceuticals and agrochemicals. Its unique structure allows for the synthesis of a wide range of bioactive compounds with potential therapeutic applications.
Used in Organic Synthesis:
2,3-DIMETHOXY-4-VINYLPYRIDINE is used as a reagent in the synthesis of various functionalized compounds. Its versatility in organic synthesis makes it a valuable component in the creation of new molecules with specific properties and applications.
Used in Polymer Production:
2,3-DIMETHOXY-4-VINYLPYRIDINE serves as a precursor in the production of polymer materials. Its incorporation into polymer structures can impart desired characteristics, such as improved stability or reactivity, to the final polymer product.
Safety Note:
It is important to handle 2,3-DIMETHOXY-4-VINYLPYRIDINE with care, as it can be hazardous if not properly managed. Proper safety measures should be taken during its use to minimize potential risks.
Check Digit Verification of cas no
The CAS Registry Mumber 944900-64-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,4,9,0 and 0 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 944900-64:
(8*9)+(7*4)+(6*4)+(5*9)+(4*0)+(3*0)+(2*6)+(1*4)=185
185 % 10 = 5
So 944900-64-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO2/c1-4-7-5-6-10-9(12-3)8(7)11-2/h4-6H,1H2,2-3H3
944900-64-5Relevant academic research and scientific papers
TRPML MODULATORS
-
Paragraph 0313, (2021/06/26)
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
ANTI-FIBROTIC PYRIDINONES
-
Paragraph 0568, (2015/11/02)
This application relates to polycyclic compounds with a pyridinone or pyridinone derivative core including, substituted pyridinones, 5,6- and 6,6- bicyclic heterocycles and substituted pyridine-thiones. This application also discloses methods of preparing these polycyclic compounds, pharmaceutical compositions and medicaments comprising said compounds and methods to treat, prevent or diagnose diseases, disorders or conditions associated with fibrosis.
ANTI-FIBROTIC PYRIDINONES
-
Paragraph 0789-0790, (2014/04/17)
Disclosed are pyridinone compounds, method for preparing these compounds, and methods for treating fibrotic disorders.
PHARMACEUTICAL COMPOUNDS
-
Page/Page column 79, (2011/04/19)
The invention relates to a series of compounds with particular activity as inhibitors of the serine-threonine kinase AKT. Also provided are pharmaceutical compositions comprising same as well as methods for treating cancer.
